Vuno
Healthcare Software · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
479 강남대로 반포동 9층, Seoul, Seoul, 06603, So...Website
www.vuno.coRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Vuno
VUNO Inc. is dedicated to discovering new biomarkers that assist in selecting or developing optimal treatment methods under the slogan 'View the Invisible, Know the Unknown.' The company offers a range of AI-driven medical solutions, including VUNO Med for chest X-ray analysis, Fundus AI for eye imaging, and DeepCARS for predicting cardiac arrest risk. Their services are aimed at healthcare professionals, enhancing daily workflows and expanding medical services into personal health management through platforms like VUNO Care-HATIV.Explore more
Vuno Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vuno your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Vuno had a recent Job posting/layoffs
Vuno, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Vuno is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Vuno recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Vuno
Website visits: Recent activity has been detected on your website
Check if Vuno has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Vuno launches new products
Funding: Get notified immidiatlly once Vuno has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Vuno is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Vuno is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Vuno.
Vuno Tech Stack
A closer look at the technologies used by Vuno
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Training, Sales, Search, Medical Research, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations, Radiology
Event
Events, Software, Healthcare Operations, Healthcare Technology, Industry Software
Event
Events, Laboratory Operations, Healthcare Technology, Operations, Radiology
New Hire
Executive Move
John Luttati has joined the organization as Vice President, North America Sales & Marketing.
Executive Moves, New Hire
New Hire
Executive Move
Vuno News & Media
Medical AI Company VUNO Reports Profit in Q3, Driven by DeepCARS Growth
- 11 Consecutive Quarters of Revenue Growth; Q3 Revenue Exceeds KRW 10 billion for the First Time SEOUL, South Korea, Nov. 12, 2025 /PRNewswire/ -- VUNO Inc., a global medical AI company, announced that it was profitable in the third quarter of 2025, recording consolidated revenue of KRW...VUNO Partners with European Firms to Advance DeepCARS® Market Entry in Europe
- Strategic MOU enhances market access and extends reach to over 900 hospitals across the region SEOUL, South Korea, Oct. 29, 2025 /PRNewswire/ -- VUNO Inc., a global medical AI company, announced today that it has signed a strategic Memorandum of Understanding (MOU) with Contextflow, an Austrian imaging AI company, and Mesalvo, a German hospital information system (HIS) provider, to jointly advance into the European market with its AI-based cardiac arrest prediction solution, VUNO Med®–DeepCARSVUNO Showcases DeepCARS® at AACN NTI 2025, Highlighting AI-Driven Cardiac Arrest Risk Prediction
– Company engages U.S. critical care professionals with data-driven early warning solution MARLBOROUGH, Mass., May 26, 2025 /PRNewswire/ -- VUNO, a global medical AI company, presented its flagship solution VUNO Med®–DeepCARS® at the 2025 National Teaching Institute & Critical Care Exposition (NTI), hosted by the American Association of Critical-Care Nurses (AACN), from May 19–21 at the Ernest N. Morial Convention Center in New Orleans. DeepCARS is an AI-powered medical device that predicts an iVUNO's AI-Powered Cardiac Arrest Risk Management System Earns CE MDR and UKCA Certifications
Early Regulatory Approval Accelerates Expansion Plans in Europe and the Middle East SEOUL, South Korea, May 12, 2025 /PRNewswire/ -- VUNO, a leading South Korean medical AI company, announced today that its flagship AI-powered cardiac arrest risk management system VUNO Med®-DeepCARS®(DeepCARS) has received CE MDR (Medical Device Regulation) certification in the European Union, as well as the UKCA (UK Conformity Assessed) mark in the United Kingdom. Achieving these regulatory milestones more than
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vuno
Sign Up For FreeTo access detailed company insights
VUNO Inc. is dedicated to discovering new biomarkers that assist in selecting or developing optimal treatment methods under the slogan 'View the Invisible, Know the Unknown.' The company offers a range of AI-driven medical solutions, including VUNO Med for chest X-ray analysis, Fundus AI for eye imaging, and DeepCARS for predicting cardiac arrest r... Read More
